US Tech & AI

Judge smacks down Texas AG’s request to immediately block Tylenol ads

In a significant ruling, a Texas judge has denied a request from Attorney General Ken Paxton to impose a temporary order against Kenvue, the manufacturer of Tylenol, preventing the company from asserting that its pain and fever medication is safe for use by pregnant women and children. This decision, made by District Judge LeAnn Rafferty in Panola County, reflects the ongoing legal and public health debate surrounding the safety of acetaminophen, the active ingredient in Tylenol, particularly in relation to claims that it may be linked to autism and other developmental disorders. These allegations have gained traction in recent years, notably after being popularized by figures such as former President Donald Trump and Robert F. Kennedy Jr., who served as an anti-vaccine advocate during the Trump administration.

Judge Rafferty’s ruling not only dismissed Paxton’s request concerning the safety claims but also rejected his attempt to block Kenvue from distributing $400 million in dividends to its shareholders later this month. This denial marks an early setback for Paxton in what is shaping up to be a politically charged legal battle. The implications of this case extend beyond the courtroom, as it raises critical questions about pharmaceutical safety, corporate accountability, and the influence of political narratives on public health policy. As the litigation unfolds, it will be essential to monitor how these claims are addressed and the potential impact on consumer trust in widely used medications like Tylenol.